CROSS-REACTIVE ANTI-VESICULAR STOMATITIS-VIRUS (VSV) CYTO-TOXIC LYMPHOCYTES-T RECOGNIZE THE MAJOR SURFACE GLYCOPROTEIN OF VSV

被引：8

作者：

HALE, AH

RUEBUSH, MJ

LEFRANCOIS, L

机构：

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 1981年 / 11卷 / 05期

关键词：

D O I：

10.1002/eji.1830110517

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：434 / 436

页数：3

相关论文

共 13 条

[1] IMMUNOLOGICAL RECOGNITION OF INFLUENZA VIRUS-INFECTED CELLS .2. EXPRESSION OF INFLUENZA A MATRIX PROTEIN ON INFECTED CELL-SURFACE AND ITS ROLE IN RECOGNITION BY CROSS-REACTIVE CYTOTOXIC-T CELLS
BRACIALE, TJ
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (03) : 673 - 689
[2] CONSERVED PEPTIDES IN THE PROTEINS OF VESICULAR STOMATITIS-VIRUS
BURGE, BW
HUANG, AS
[J]. VIROLOGY, 1979, 95 (02) : 445 - 453
[3] VESICULAR STOMATITIS-VIRUS GLYCOPROTEIN IS NECESSARY FOR H-2-RESTRICTED LYSIS OF INFECTED-CELLS BY CYTOTOXIC T LYMPHOCYTES
HALE, AH
WITTE, ON
BALTIMORE, D
EISEN, HN
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (02) : 970 - 974
[4] CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR VESICULAR STOMATITIS-VIRUS RECOGNIZE THE MAJOR SURFACE GLYCOPROTEIN OF VSV
HALE, AH
RUEBUSH, MJ
MCGEE, MP
[J]. ANTIVIRAL RESEARCH, 1981, 1 (01) : 63 - 70
[5] ANTIGEN-LIPOSOME MODIFICATION OF TARGET-CELLS AS A METHOD TO ALTER THEIR SUSCEPTIBILITY TO LYSIS BY CYTO-TOXIC LYMPHOCYTES-T
HALE, AH
RUEBUSH, MJ
LYLES, DS
HARRIS, DT
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10): : 6105 - 6108
[6] HALE AH, 1980, J IMMUNOL, V124, P724
[7] RECOGNITION OF VIRAL GLYCOPROTEINS BY INFLUENZA A-SPECIFIC CROSS-REACTIVE CYTOLYTIC LYMPHOCYTE-T
KOSZINOWSKI, UH
ALLEN, H
GETHING, MJ
WATERFIELD, MD
KLENK, HD
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (04) : 945 - 958
[8] SYNTHETIC PHOSPHOLIPID-VESICLES CONTAINING A PURIFIED VIRAL-ANTIGEN AND CELL-MEMBRANE PROTEINS STIMULATE THE DEVELOPMENT OF CYTOTOXIC LYMPHOCYTES-T
LOH, D
ROSS, AH
HALE, AH
BALTIMORE, D
EISEN, HN
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (05) : 1067 - 1074
[9] ROSENTHAL KL, 1980, J IMMUNOL, V124, P2301
[10] RUEBUSH MJ, 1981, J IMMUNOL, V126, P2053